Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins
about
Host restriction factors for hepatitis C virusHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionChronic hepatitis C virus infection and lipoprotein metabolismStructural and Functional Properties of the Hepatitis C Virus p7 ViroporinGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignHCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated PathogenesisCell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5AProteomic approaches to analyzing hepatitis C virus biologyCoordination of Hepatitis C Virus Assembly by Distinct Regulatory Regions in Nonstructural Protein 5AHepatitis C Virus Is Released via a Noncanonical Secretory Route.Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolismRegulated Entry of Hepatitis C Virus into Hepatocytes.Hepatitis C virus life cycle and lipid metabolismSeveral Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released VirusesThe Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion.Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the VirusApolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse ModelNonstructural 5A Protein of Hepatitis C Virus Regulates Soluble Resistance-Related Calcium-Binding Protein Activity for Viral Propagation.Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle FormationOpportunistic intruders: how viruses orchestrate ER functions to infect cells.Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus.Lipoprotein lipase liberates free fatty acids to inhibit HCV infection and prevent hepatic lipid accumulation.Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux.Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.Ultrastructural and biochemical basis for hepatitis C virus morphogenesis.Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.Hepatitis C Virus Lipoviroparticles Assemble in the Endoplasmic Reticulum (ER) and Bud off from the ER to the Golgi Compartment in COPII Vesicles.A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner.Green fluorescent protein-tagged apolipoprotein E: A useful marker for the study of hepatic lipoprotein egress.Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels.Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.HCV envelope glycoproteins in evirion assembly and entryFunctional Study of the C-Terminal Part of the Hepatitis C Virus E1 EctodomainHepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder
P2860
Q26773258-1A9E117E-24E4-46D8-82CD-705AFF75C1E0Q26779128-810DAD7A-5C0C-4AEC-8924-31173CE80135Q26784234-DB406BCF-0FB5-4231-82FA-89D94CE8C295Q26799884-D88D56AA-31B0-439C-9B50-48A97AD67F0CQ26801759-7E66D988-48DC-49FC-988E-AF53198E86DBQ26996778-23981813-1A48-45D8-9AEC-B1651DAA892BQ27469080-1C852B28-A307-48C5-9D19-EE05D24DE60CQ28085146-F1B29C01-6B51-4AC7-B990-DEC54DE7AA54Q28551959-105BE261-A207-438F-8887-11054223913BQ30828742-8EF7D810-3776-4786-9B4E-9A624435DC11Q33747040-8FB98EFA-07A2-4351-BA8D-26E8903E967BQ33753913-203FB757-ED6A-4D58-9BE1-AC19F57366C3Q34792436-CD603A2C-074A-436F-A2B7-769A91F65FE0Q35727227-C30429A7-419C-49FB-ACBB-20833FE5714BQ35764429-F8F8C63B-9372-4780-AC9F-F25AE1874BDAQ35821487-FEA5AB2D-8CC0-49BC-A407-7203CEE678DDQ36233117-4AE146C0-88AF-4820-9077-1D8B7A8627BCQ36281615-188E4BFB-B884-471B-9085-87AEAE0F48FFQ36736693-ABB84231-F43C-4A7F-9701-46A3F69B97A9Q37252970-4821D9A7-B536-45E0-BBD1-57FBD0212D87Q37610842-E1CCD852-20A9-4856-9947-F96F2C1DE506Q38702378-2FE96F5B-733F-49D2-AEA1-DCA4E8ABBAE5Q38735167-DF0AA15C-7991-4364-9E29-583BB3B2B9B4Q38743914-E1C872D8-80CC-4014-8F96-A15CDEB549D9Q38747495-2AEF18D6-D602-4FA9-94A2-27018B369371Q38985716-49A7A561-029A-40F8-A6B4-CE537F8D7C42Q39148859-B2DFA91A-BAC8-4138-B0D6-7A816AA41330Q39380623-37712C90-F261-4B4D-91D8-F7584AE1C4F1Q39443793-F346F2DB-94C0-47B1-97B4-1B8E0E9CDF07Q39480497-549C7A5A-0BFE-4967-8116-1C148172B65CQ40141933-CC93203C-CC7D-4431-B80E-CFD17C338B52Q40197746-F6CF832F-50E5-4D5C-A5E2-9FF9E325F559Q40278524-8281D4C4-E4CD-4039-A3D9-F0E70E826488Q40390599-14AFF213-4329-4D06-9787-7003B302621BQ40635705-E65DF214-0855-4065-A046-2C0AB4BC4E48Q55473444-C499FBB5-2F35-4990-9965-0D333D070EFAQ55513556-20470221-1676-488A-B5EF-7463FA5DC693Q56910948-D22F0AB4-F6E7-43BC-A5E2-0BDEE32493A3Q56926489-075FB656-36F8-498D-947D-115F5A94E0A9Q57265415-8DE8CAAD-81A4-4BAD-9C8D-32559000C990
P2860
Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@ast
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@en
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@en-gb
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@nl
type
label
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@ast
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@en
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@en-gb
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@nl
prefLabel
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@ast
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@en
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@en-gb
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Apolipoprotein E likely contri ...... h viral envelope glycoproteins
@en
P2093
Birthe Mueller
Eliana G Acosta
Ina Karen Stoeck
Ji-Young Lee
Marie-Sophie Hiet
Stephanie Kallis
P2860
P304
P3181
P356
10.1128/JVI.01660-14
P407
P577
2014-11-01T00:00:00Z